TRAVERE THERAPEUTICS, INC. Debt Instrument, Interest Rate, Effective Percentage
TRAVERE THERAPEUTICS, INC. (TVTX) had Debt Instrument, Interest Rate, Effective Percentage of 7.70% as of 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateEffectivePercentage · last filed 2022-02-24
- 2021-12-31: Debt Instrument, Interest Rate, Effective Percentage 7.70%.
- 2020-12-31: Debt Instrument, Interest Rate, Effective Percentage 7.70%.
- 2019-12-31: Debt Instrument, Interest Rate, Effective Percentage 7.70%.
- 2018-09-30: Debt Instrument, Interest Rate, Effective Percentage 7.70%.
| Period end | Debt Instrument, Interest Rate, Effective Percentage |
|---|---|
| 2021-12-31 | 7.70% 10-K · filed 2022-02-24 |
| 2020-12-31 | 7.70% 10-K · filed 2022-02-24 |
| 2019-12-31 | 7.70% 10-K · filed 2022-02-24 |
| 2018-09-30 | 7.70% 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |